High Tower Advisors, LLC Aerie Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$7.02 - $13.33 $178,876 - $339,661	-25,481 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $19,708 - $28,952	-1,741 Reduced 6.4%	25,481 $287,000
Q2 2021 Aug 06, 2021	BUY	$15.16 - $18.97 $37,005 - $46,305	2,441 Added 9.85%	27,222 $437,000
Q1 2021 May 10, 2021	BUY	$13.12 - $20.9 $102,257 - $162,894	7,794 Added 45.88%	24,781 $441,000
Q4 2020 Feb 10, 2021	BUY	$9.12 - $14.49 $154,921 - $246,141	16,987 New	16,987 $228,000
Q1 2020 May 21, 2020	SELL	$11.84 - $25.52 $106,370 - $229,271	-8,984 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $159,196 - $225,498	8,984 New	8,984 $217,000
Q3 2017 Nov 14, 2017	SELL	$48.6 - $60.1 $238,577 - $295,030	-4,909 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	4,909	4,909 $256,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.